Identification of Arsenic Direct-Binding Proteins in Acute Promyelocytic Leukaemia Cells
The identification of arsenic direct-binding proteins is essential for determining the mechanism by which arsenic trioxide achieves its chemotherapeutic effects. At least two cysteines close together in the amino acid sequence are crucial to the binding of arsenic and essential to the identification...
Main Authors: | Tao Zhang, Haojie Lu, Weijun Li, Ronggui Hu, Zi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/11/25994 |
Similar Items
-
Severe acute axonal neuropathy following treatment with arsenic trioxide for acute promyelocytic leukemia: a case report
by: Marcus Kuhn, et al.
Published: (2016-05-01) -
On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
by: Peng Zhang
Published: (2017-01-01) -
Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
by: Li Zhang, et al.
Published: (2018-04-01) -
Pharmacokinetic Characteristics, Tissue Bioaccumulation and Toxicity Profiles of Oral Arsenic Trioxide in Rats: Implications for the Treatment and Risk Assessment of Acute Promyelocytic Leukemia
by: Wensheng Liu, et al.
Published: (2021-05-01) -
Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death
by: Zhang Y, et al.
Published: (2018-09-01)